Evidence map›Paper›PMID 40337507›Full record

ArticleFrontiers in pharmacology2025

Deciphering metabolic disease mechanisms for natural medicine discovery via graph autoencoders.

Qingquan Liao, Wei Zhao, Zhan Wang, Lei Xu, Kun Yang, Xinxin Liu, Lichao Zhang

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qingquan LiaoDepartment of Information Technology, Hunan Police Academy, Changsha, China.
Wei ZhaoDepartment of Information Technology, Hunan Police Academy, Changsha, China.
Zhan WangSchool of Electronic and Communication Engineering, Shenzhen Polytechnic University, Shenzhen, China.
Lei XuSchool of Electronic and Communication Engineering, Shenzhen Polytechnic University, Shenzhen, China.
Kun YangSchool of Data Science and Artificial Intelligence, Wenzhou University of Technology, Wenzhou, China.
Xinxin LiuSchool of Data Science and Artificial Intelligence, Wenzhou University of Technology, Wenzhou, China.
Lichao ZhangSchool of Intelligent Manufacturing and Equipment, Shenzhen Institute of Information Technology, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic diseases, such as diabetes, pose significant risks to human health due to their complex pathogenic mechanisms, complicating the use of combination drug therapies. Natural medicines, which contain multiple bioactive components and exhibit fewer side effects, offer promising therapeutic potential. Metabolite imbalances are often closely associated with the pathogenesis of metabolic diseases. Therefore, metabolite detection not only aids in disease diagnosis but also provides insights into how natural medicines regulate metabolism, thereby supporting the development of preventive and therapeutic strategies. Deep learning has shown remarkable efficacy and precision across multiple domains, particularly in drug discovery applications. Building on this, We developed an innovative framework combining graph autoencoders (GAEs) with non-negative matrix factorization (NMF) to investigate metabolic disease pathogenesis via metabolite-disease association analysis. First, we applied NMF to extract discriminative features from established metabolite-disease associations. These features were subsequently integrated with known relationships and processed through a GAE to identify potential disease mechanisms. Comprehensive evaluations demonstrate our method's superior performance, while case studies validate its capability to reveal pathological mechanisms in metabolic disorders including diabetes. This approach may facilitate the development of natural medicine-based interventions. Our data and code are available at: https://github.com/Lqingquan/natural-medicine-discovery.

Indexed as

drug discoverygraph autoencodermetabolic diseasesmetabolite-disease associationsnatural medicines

Identifiers

PMID40337507
PMCPMC12055761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.